215 related articles for article (PubMed ID: 35456040)
21. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation.
Wei C; Li X
BMC Cancer; 2020 Oct; 20(1):1042. PubMed ID: 33121449
[TBL] [Abstract][Full Text] [Related]
22. The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.
Lui JW; Xiao S; Ogomori K; Hammarstedt JE; Little EC; Lang D
J Cancer; 2019; 10(1):1-10. PubMed ID: 30662519
[TBL] [Abstract][Full Text] [Related]
23. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
24. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
[TBL] [Abstract][Full Text] [Related]
25. Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein Survivin in a light-independent manner.
Hasegawa T; Sugihara T; Hoshino Y; Tarumoto R; Matsuki Y; Kanda T; Takata T; Nagahara T; Matono T; Isomoto H
Oncol Lett; 2021 Oct; 22(4):703. PubMed ID: 34457058
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.
Bouvier C; Macagno N; Nguyen Q; Loundou A; Jiguet-Jiglaire C; Gentet JC; Jouve JL; Rochwerger A; Mattei JC; Bouvard D; Salas S
Oncotarget; 2016 Oct; 7(40):64702-64710. PubMed ID: 27608849
[TBL] [Abstract][Full Text] [Related]
27. Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension.
Xu Q; Zhuo K; Cai R; Su X; Zhang L; Liu Y; Zhu L; Ren F; Zhou MS
Front Physiol; 2021; 12():732084. PubMed ID: 34650444
[TBL] [Abstract][Full Text] [Related]
28. The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis.
Kovar H; Bierbaumer L; Radic-Sarikas B
Cells; 2020 Apr; 9(4):. PubMed ID: 32326412
[TBL] [Abstract][Full Text] [Related]
29. Determination of the migration effect and molecular docking of verteporfin in different subtypes of breast cancer cells.
Wei C; Li X
Mol Med Rep; 2020 Nov; 22(5):3955-3961. PubMed ID: 32901856
[TBL] [Abstract][Full Text] [Related]
30. USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ.
Yuan P; Feng Z; Huang H; Wang G; Chen Z; Xu G; Xie Z; Jie Z; Zhao X; Ma Q; Wang S; Shen Y; Huang Y; Han Y; Ye H; Wang J; Shi P; Sun X
Int J Biol Sci; 2022; 18(8):3122-3136. PubMed ID: 35637948
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
Zoumpoulidou G; Alvarez-Mendoza C; Mancusi C; Ahmed RM; Denman M; Steele CD; Tarabichi M; Roy E; Davies LR; Manji J; Cristalli C; Scotlandi K; Pillay N; Strauss SJ; Mittnacht S
Nat Commun; 2021 Dec; 12(1):7064. PubMed ID: 34862364
[TBL] [Abstract][Full Text] [Related]
32. Verteporfin-loaded microparticles for radiosensitization of preclinical lung and breast metastatic spine cancer.
Akinduro OO; Suarez-Meade P; Roberts M; Tzeng SY; Sarabia-Estrada R; Schiapparelli P; Norton ES; Gokaslan ZL; Anastasiadis PZ; Guerrero-Cázares H; Green JJ; Quiñones-Hinojosa A
J Neurosurg Spine; 2023 Apr; 38(4):481-493. PubMed ID: 36585863
[TBL] [Abstract][Full Text] [Related]
33. YAP/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast Like Synoviocytes Phenotype and Fibro-Inflammatory Response.
Caire R; Audoux E; Courbon G; Michaud E; Petit C; Dalix E; Chafchafi M; Thomas M; Vanden-Bossche A; Navarro L; Linossier MT; Peyroche S; Guignandon A; Vico L; Paul S; Marotte H
Front Immunol; 2021; 12():791907. PubMed ID: 34956224
[TBL] [Abstract][Full Text] [Related]
34. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
[TBL] [Abstract][Full Text] [Related]
35. Verteporfin Suppresses YAP-Induced Glycolysis in Breast Cancer Cells.
Chen H; Zhang LF; Miao Y; Xi Y; Li X; Liu MF; Zhang M; Li B
J Invest Surg; 2023 Dec; 36(1):2266732. PubMed ID: 37828756
[TBL] [Abstract][Full Text] [Related]
36. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
37. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
[TBL] [Abstract][Full Text] [Related]
38. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells.
Zhou W; Lim A; Elmadbouh OHM; Edderkaoui M; Osipov A; Mathison AJ; Urrutia R; Liu T; Wang Q; Pandol SJ
Free Radic Biol Med; 2024 Feb; 212():493-504. PubMed ID: 38184120
[TBL] [Abstract][Full Text] [Related]
39. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
Konishi T; Schuster RM; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
[TBL] [Abstract][Full Text] [Related]
40. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Nishina H
Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
